The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index; 4 of the 13 sources its claims cite were checked for support.
Onset of Addison Disease in a Patient Using the Advanced Hybrid Closed-Loop MiniMed 780G: Diagnostic Challenges
Open accessAbstract
This case report describes a 25-year-old woman with type 1 diabetes mellitus (T1DM) and autoimmune thyroid disease (AITD) who developed Addison disease (AD). The diagnosis was suspected due to a significant decrease in insulin requirement and recurrent hypoglycemia despite adjustments in insulin pump therapy.
Overview
CoChat Summary
## TL;DR
This case report describes a 25-year-old woman with type 1 diabetes and autoimmune thyroid disease whose falling insulin needs and recurrent hypoglycemia on a MiniMed 780G system helped reveal new-onset Addison disease. The paper emphasizes that in people with T1DM, a progressive drop in insulin requirement plus hypoglycemia should prompt evaluation for adrenal insufficiency.
## Key findings
- The patient’s glycemic metrics worsened before diagnosis, with time below range rising to 6% in January 2024 and daily insulin needs falling by 30%, from 35 units to 24 units in April 2024.
- At emergency presentation she had hypotension (85/50 mmHg), hypoglycemia (45 mg/dL), hyponatremia (Na 117 mEq/L), and hyperkalemia (K 5.7 mEq/L), with skin and mucosal hyperpigmentation.
- Diagnostic testing supported primary adrenal insufficiency: 8 AM cortisol 2 µg/dL, ACTH 1223 pg/mL, renin 314,000 mUI/L, and aldosterone 2.58 ng/dL; 21-alpha hydroxylase antibodies were positive.
- After hydrocortisone and fludrocortisone replacement, symptoms improved and insulin needs later increased again; by October 2024, the ambulatory glucose profile showed TIR 74%, TBR 1%, and TAR 24%, with insulin use rising from 30 units in March 2024 to 50 units daily four months later.
## Methods
- Single-patient case report of a 25-year-old woman with longstanding T1DM and autoimmune hypothyroidism/AITD using an advanced hybrid closed-loop MiniMed 780G insulin pump.
- Data came from routine endocrinology follow-up, emergency evaluation, glucose-monitoring downloads (including CareLink), laboratory testing, and autoimmune studies.
- Main analysis was clinical interpretation of evolving insulin requirements, hypoglycemic trends, vital signs, electrolytes, and adrenal-axis labs to identify Addison disease.
## Limitations
- The paper is a single case report, so its observations may not generalize beyond this patient.
- The text does not provide a comparative group or formal statistical analysis; this is evident from the case-report design.
- Not stated in the paper: the authors do not describe a structured long-term outcome beyond follow-up through October 2024.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
3 Valid · 4 Not valid · 8 Not checked · 31 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Recently, a case report described an adolescent girl with T1DM and subsequent latent AD, which was diagnosed based on a recurrent hypoglycemic trend detected by continuous glucose monitoring (CGM) [4].”
§ Onset of Addison Disease in a Patient Using the Advanced Hybrid Closed-Loop MiniMed 780G: Diagnostic Challenges > Introduction
What the sources say
- Supportedcites [4] Vinci, 2021, Type 1 diabetes and Addison's disease: when the diagnosis is suggested by the continuous glucose monitoring system, Children (Basel) source
The Introduction describes a young girl with type 1 diabetes whose latent adrenal insufficiency was suspected after a recurrent hypoglycemic trend appeared in CGM data. The Case Report describes the near-dawn trend and explains that adrenal testing subsequently confirmed the diagnosis. (LLM, conf=0.94)
plainstates a causeSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Since the risk of developing AD is 10 times higher in patients with T1DM than in the general population, and the combination of concomitant T1DM and AD is associated with a more than 4-fold increase in the risk of premature death compared with patients with T1DM alone, awareness of this risk is of paramount importance to physicians managing patients with T1DM [6, 7].”
§ Onset of Addison Disease in a Patient Using the Advanced Hybrid Closed-Loop MiniMed 780G: Diagnostic Challenges > Discussion
What the sources say
- Partly supportedcites [6] Dittmar, 2003, Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up, J Clin Endocrinol Metab sourceExperimental — accuracy not yet measured
The “Comparison of type 1 diabetes patients vs. patients with PAS II” section reports adrenal failure in 4.2% of 471 patients with type 1 diabetes. It gives no general-population comparison or tenfold estimate for developing Addison disease. The paper’s separate “10 times” figure concerns islet autoantibodies in offspring with particular genotypes, not Addison disease. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [7] Betterle, 2002, Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction [published correction appears in Endocr Rev. 2002 Aug;23(4):579.], Endocr Rev source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The mechanisms of hypoglycemia in primary adrenal insufficiency are primarily due to cortisol deficiency.”
§ Onset of Addison Disease in a Patient Using the Advanced Hybrid Closed-Loop MiniMed 780G: Diagnostic Challenges > Discussion
What the sources say
- Supportedcites [8] Lee, 2023, Hypoglycaemia in adrenal insufficiency, Front Endocrinol (Lausanne) source
The Abstract identifies primary adrenal insufficiency as directly impairing cortisol production and describes cortisol as key to preventing hypoglycaemia. The Aetiology section explains that cortisol deficiency increases insulin sensitivity, reduces endogenous glucose production and increases glucose oxidation, supporting the claimed mechanism. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The patient exhibited typical clinical features of AD, including hyperpigmentation and electrolyte imbalances.”
§ Onset of Addison Disease in a Patient Using the Advanced Hybrid Closed-Loop MiniMed 780G: Diagnostic Challenges > Abstract
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“At this visit, the patient complained that her glycemic control had deteriorated due to an increase in the percentage of hypoglycemia (TIR 82%, TBR 6%, and TAR 12% in January 2024, see Table 1).”
§ Onset of Addison Disease in a Patient Using the Advanced Hybrid Closed-Loop MiniMed 780G: Diagnostic Challenges > Case Presentation
plainstates a causeSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
16 more claims
Create a free account to see all 46 claims and every source verdict.
- Probably not a substantial claim. 9
- It may state two separate claims as one. 19
Citations
Cites
Betterle, C., Dal Pra, C., Mantero, F., & Zanchetta, R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0466 · Cited by 758 · cited 1×
“…than in the general population, and the combination of concomitant T1DM and AD is associated with a more than 4-fold increase in the risk of premature death compared with patients with T1DM alone, awareness of this risk is of paramount importance to physicians managing patients with T1DM [6, 7].”
Polyglandular Autoimmune Syndromes: Immunogenetics and Long-Term Follow-Up
Dittmar, M., & Kahaly, G. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021845 · Cited by 367 · cited 1×
“…than in the general population, and the combination of concomitant T1DM and AD is associated with a more than 4-fold increase in the risk of premature death compared with patients with T1DM alone, awareness of this risk is of paramount importance to physicians managing patients with T1DM [6, 7].”
7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281 · cited 1×
“This demonstrates how well and quickly the Smartguard technology from the MM780g adapts to the patient’s insulin needs [9].”
Hypoglycaemia in adrenal insufficiency
Lee, S. C., Baranowski, E. S., Sakremath, R., Saraff, V., & Mohamed, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1198519 · Cited by 42 · cited 1×
“A lack of cortisol also compromises the normal counter-regulatory response to hypoglycemia, since cortisol is necessary for catecholamines and glucagon to have their full effect in raising blood glucose [8].”
Armstrong, L., & Bell, P. M. (1996) · BMJ · doi:10.1136/bmj.312.7046.1601 · Cited by 36 · cited 1×
“Conversely, in the absence of physiological levels of circulating glucocorticoids, insulin sensitivity is increased [3].”
Chantzichristos, D., Persson, A., Eliasson, B., Miftaraj, M., Franzén, S., Bergthorsdottir, R., Gudbjörnsdottir, S., Svensson, A.-M., & Johannsson, G. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0657 · Cited by 30 · cited 1×
“After initiation of glucocorticoids, case reports often mention an increase in insulin requirements to previous levels and a reversal of hypoglycemia after initiation of glucocorticoid replacement therapy, which was also observed in this patient [10].”
Chantzichristos, D., Eliasson, B., & Johannsson, G. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0052 · Cited by 21 · cited 1×
“While the percentage of daily coverage with basal insulin was lower in patients with adrenal insufficiency, the insulin requirement for prandial glycemic coverage was higher in patients with APS2 [12].”
Síndromes pluriglandulares autoinmunes
Fernández-Miró, M., Comi, C. C., & Lorenzo, R. G. (2021) · Medicina Clínica · doi:10.1016/j.medcli.2021.02.004 · Cited by 12
Chantzichristos, D., Persson, A., Miftaraj, M., Eliasson, B., Svensson, A.-M., & Johannsson, G. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02064 · Cited by 9 · cited 1×
“Patients with an autoimmune disorder, such as T1DM, are at an increased risk of developing another autoimmune disease, such as AD, AITD, celiac disease, pernicious anemia, or rheumatoid disease [5].”
Vinci, F., d’Annunzio, G., Napoli, F., Bassi, M., Montobbio, C., Ferrando, G., & Minuto, N. (2021) · Children · doi:10.3390/children8080702 · Cited by 9 · cited 1×
“Recently, a case report described an adolescent girl with T1DM and subsequent latent AD, which was diagnosed based on a recurrent hypoglycemic trend detected by continuous glucose monitoring (CGM) [4].”
Research works printed but not linked: 1
- Sperling, 2024, Endotext
Metadata
- Authors
- Mera-Carreiro, S., Jiménez-Varas, I., Martínez-Suero, L., Sánchez-Maroto-García, N., De-Miguel-Novoa, P., & Cuesta-Hernández, M.
- Affiliations
- Servicio de Endocrinología y Nutrición, Hospital HM Madrid Río, HM Hospitales , Madrid 28005 ,
- Hospital Clínico San Carlos (ES)
- Servicio de Endocrinología y Nutrición, Hospital Universitario Clínico San Carlos , Madrid 28040 ,
- ORCID
- Mera-Carreiro, Sara
- Venue
- JCEM Case Reports
- Publisher
- The Endocrine Society
- Published
- 2025-08-19
- Volume
- 3
- Issue
- 10
- Pages
- luaf181-luaf181
- ISSN
- 2755-1520 (ISSN-L)
- PMC
- PMC12399366
- OpenAlex
- W4413867849
- Cited by
- 0
- References
- 11
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- JCEM Case Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- Addison's disease, type 1 diabetes, autoimmune thyroid disease, MiniMed 780G, adrenal insufficiency, hypoglycemia, insulin requirement, hyperpigmentation, electrolyte imbalance, adrenal crisis, continuous glucose monitoring, autoimmune disease comorbidity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Onset of Addison Disease in a Patient Using the Advanced Hybrid Closed-Loop MiniMed 780G: Diagnostic Challenges. https://app.cochat.ai/papers/10.1210/jcemcr/luaf181
- The paper
- Mera-Carreiro, S., Jiménez-Varas, I., Martínez-Suero, L., Sánchez-Maroto-García, N., De-Miguel-Novoa, P., & Cuesta-Hernández, M. (2025). Onset of Addison Disease in a Patient Using the Advanced Hybrid Closed-Loop MiniMed 780G: Diagnostic Challenges. JCEM Case Reports. https://doi.org/10.1210/jcemcr/luaf181
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

